Influence of combined eplerenone, aflibercept and nepafenac therapy on central serous chorioretinopathy
Using topical nepafenac in combination with both systemic eplerenone, and intravitreal aflibercept may provide better results in the treatment of CSCR.
Authors
- Fayrouz Aboalazayem (ORCID: https://orcid.org/0000-0002-1302-6205)
- Wael Ahmed Ewais (ORCID: https://orcid.org/0000-0001-8135-4123)
Institutions
- Cairo University (EG)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.18240/ijo.2025.06.12
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00